Pharmacological treatment of depression in people with a primary brain tumour - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Background Patients with a primary brain tumour often experience depression, for which
drug treatment may be prescribed. However, these patients are also at high risk of epileptic …

Background Evidence is limited regarding the most effective pharmacological treatment for
psychotic depression: combination of an antidepressant plus an antipsychotic, monotherapy …

Background Evidence is limited regarding the most effective pharmacological treatment for
psychotic depression: monotherapy with an antidepressant, monotherapy with an …

Background Major depression and other depressive conditions are common in people with
cancer. These conditions are not easily detectable in clinical practice, due to the overlap …

Background Following traumatic brain injury (TBI) there is an increased prevalence of
depression compared to the general population. It is unknown whether non …

Background Depression is a common problem in patients with multiple sclerosis (MS). It is
unclear which pharmacologic treatment is the most effective and the least harmful …

Background There are no recommendations based on the efficacy of specific drugs for the
treatment of psychotic depression. To address this evidence gap, we did a network meta …

BackgroundDepression is a leading cause of disease burden worldwide and is especially
problematic in people with chronic diseases, including cancer. Although depression can be …

Background Depression in the physically unwell is common and an important cause of
morbidity. There are problems with diagnosing depression in the physically ill which may …